See All Slides - tctmd.com

Slides

Presentation TCT 2012

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

Presenter: Eugenio Stabile

October 22, 2012

Presentation TCT 2012

From Hardware (Devices) to Software (Information Technology): How the Digital Revolution Will Change Medical Innovation

Presenter: Peter Fitzgerald

October 22, 2012

Presentation TCT 2012

Non-Left Main Bifurcation PCI: Integrated Use of FFR and IVUS

Presenter: Soo-Jin Kang

October 22, 2012

Presentation TCT 2012

Case Presentation(3)

Presenter: Joachim Schofer

October 22, 2012

Presentation TCT 2012

RESPECT: Late Breaking Trial Preview

Presenter: John Carroll

October 22, 2012

Presentation TCT 2012

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Presenter: Felix Woitek

October 22, 2012

Presentation TCT 2012

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

Presenter: David Cormode

October 22, 2012

Presentation TCT 2012

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

Presenter: David Kandzari

October 22, 2012

Presentation TCT 2012

Uses and Utility of IVUS During Bifurcation Stenting

Presenter: Akiko Maehara

October 22, 2012

Presentation TCT 2012

AND, Should Also be Based on Hemodynamic Assessments: The Dimensionless AR Index

Presenter: Georg Nickenig

October 22, 2012

Advertisement

Slides

Drug-Coated Balloons for SFA In-Stent Restenosis: A Simple Solution for a Tenacious Problem?

From Hardware (Devices) to Software (Information Technology): How the Digital Revolution Will Change Medical Innovation

Non-Left Main Bifurcation PCI: Integrated Use of FFR and IVUS

Case Presentation(3)

RESPECT: Late Breaking Trial Preview

TCT-108: Performance and Safety of the TRUE Dilatation Balloon Valvuloplasty Catheter for Aortic Balloon Valvuloplasty in Patients Undergoing TAVR

Emerging Applications of Nanotechnology for the Diagnosis and Management of Vulnerable Atherosclerotic Plaque

Rationale and Data for Different DAPT Durations: From 3 to 30 Months (or Longer)

Uses and Utility of IVUS During Bifurcation Stenting

AND, Should Also be Based on Hemodynamic Assessments: The Dimensionless AR Index

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content